It's marketing's biggest night! Outside of the actual game and the famed halftime show, many viewers tune into the Super Bowl ...

If you buy something, we may earn an affiliate commission. Nobody really looks forward to reading a Hims review. But hair loss comes for us all eventually—no matter how much you deny it or ...

The ad also marks a pivot for the telehealth company colloquially known as Hims, which rose to prominence just under a decade ago, slickly marketing hair-loss treatments and erectile-dysfunction ...

For more intense color, you can towel dry your hair before you spray. Promising review: "I absolutely love this stuff. There's no commitment and no staining the hair. It is literally a put-in-and ...

Hims and Roman are telehealth companies that sell prescription and nonprescription products to treat erectile dysfunction (ED), hair loss, and premature ejaculation (PE). Both ED and hair loss can ...

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%, and achieved a full year of operating and net income profitability. Despite strong fundamentals, HIMS stock price has ...

Hims & Hers sells a compounded weight loss medication. A telehealth company that sells a compounded version of medications used for weight loss has found itself at the center of an escalating ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the ...

Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth company. A big part of that is related to its Super Bowl LIX ad ...